In lung cancer models, Sosa MS and colleagues demonstrated that Nuclear Receptor Subfamily 2 Group F Member 1 (NR2F1) is commonly downregulated via promoter hypermethylation during active tumor proliferation, whereas it is significantly upregulated during cellular dormancy [47]. Here, NR2F1 is linked to lung cancer.